Your browser doesn't support javascript.
loading
Sequential use of second-generation tyrosine kinase inhibitors following imatinib therapy in pediatric chronic myeloid leukemia: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group.
Kurosawa, Hidemitsu; Tanizawa, Akihiko; Muramatsu, Hideki; Tono, Chikako; Watanabe, Akihiro; Shima, Haruko; Ito, Masaki; Yuza, Yuki; Hamamoto, Kazuko; Hotta, Noriko; Okada, Masahiko; Saito, Akiko Moriya; Manabe, Atsushi; Mizutani, Shuki; Adachi, Souichi; Horibe, Keizo; Ishii, Eiichi; Shimada, Hiroyuki.
Afiliação
  • Kurosawa H; Department of Pediatrics, Dokkyo Medical University School of Medicine, Tochigi, Japan.
  • Tanizawa A; Department of Human Resource Development for Cancer, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
  • Muramatsu H; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Tono C; Department of Pediatrics, Iwate Prefectural Chubu Hospital, Iwate, Japan.
  • Watanabe A; Department of Pediatrics, Niigata Cancer Center Hospital, Niigata, Japan.
  • Shima H; Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.
  • Ito M; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Yuza Y; Department of Pediatrics, Soma General Hospital, Fukushima, Japan.
  • Hamamoto K; Department of Hematology and Oncology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
  • Hotta N; Department of Pediatrics, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan.
  • Okada M; Department of Pediatrics, Japan Community Healthcare Organization Tokuyama Central Hospital, Tokuyama, Japan.
  • Saito AM; Department of Pediatrics, Nagasaki University School of Medicine, Nagasaki, Japan.
  • Manabe A; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Mizutani S; Department of Pediatrics, St. Luke's International Hospital, Tokyo, Japan.
  • Adachi S; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan.
  • Horibe K; Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Ishii E; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Shimada H; Department of Pediatrics, Ehime University Graduate School of Medicine, Ehime, Japan.
Pediatr Blood Cancer ; 65(12): e27368, 2018 12.
Article em En | MEDLINE | ID: mdl-30084127
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Inibidores de Proteínas Quinases / Mesilato de Imatinib / Dasatinibe Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Inibidores de Proteínas Quinases / Mesilato de Imatinib / Dasatinibe Idioma: En Ano de publicação: 2018 Tipo de documento: Article